Delivery Order SPE2DB20D2014-SPE2DB24FB74V
- Not listed
- This federal contract award is for the delivery of fluticasone propionate HFA 44 mcg inhalers to the Defense Logistics Agency (DLA). The contract, valued at $38,854.35, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is October 18, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $1,041.72 and a period of performance through November 3, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $1,066.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 20, 2025 and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of fluticasone propionate HFA 220 mcg 12 gm inhalers to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $3,369.53. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12g inhalers. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,991.70 and a completion date of May 28, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- The federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $9,255.34 firm fixed price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $5,167.84 to Amerisourcebergen Drug Corp, a for-profit organization, to provide fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a completion date of February 9, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalation aerosol to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,574.26. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,738.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone propionate HFA 110 mcg inhalers, with a completion date of April 30, 2025. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm inhalers. The $1,506.94 Firm Fixed Price delivery order was awarded by the Defense Logistics Agency Troop Support Medical, a defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB74VDelivery Order
This federal contract award is for the delivery of fluticasone propionate HFA (hydrofluoroalkane) inhalers, with a ceiling value of $1,046.32. The contracting agency is the Defense Logistics Agency (DLA), a defense agency, and the prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 30, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/29/24 |